GRFS

About Grifois, S.A. (GRFS) Stock

Grifois, S.A. (GRFS) closed the 2026-09-16 session at $7.40, up 0.54% versus the previous close (+0.04). The stock opened at $7.41 and traded between $7.34 and $7.41 during that session. Session trading volume was 472K shares. The volume-weighted average price (VWAP) is $7.38.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Grifois, S.A. has a market capitalization of $5.04 billion. GRFS is listed on the XNAS exchange. The company employs approximately 25,247 people. The recorded listing date is 2011-06-02.

On this page you can find market GRFS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.